ACY1 (Aminoacylase 1) monoclonal antibody MB62045
Specifications
| 50ul/100ul |
Background:
This gene encodes a cytosolic, homodimeric, zinc-binding enzyme that catalyzes the hydrolysis of acylated L-amino acids to L-amino acids and an acyl group, and has been postulated to function in the catabolism and salvage of acylated amino acids. This gene is located on chromosome 3p21.1, a region reduced to homozygosity in small-cell lung cancer (SCLC), and its expression has been reported to be reduced or undetectable in SCLC cell lines and tumors. The amino acid sequence of human aminoacylase-1 is highly homologous to the porcine counterpart, and this enzyme is the first member of a new family of zinc-binding enzymes. Mutations in this gene cause aminoacylase-1 deficiency, a metabolic disorder characterized by central nervous system defects and increased urinary excretion of N-acetylated amino acids. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream ABHD14A (abhydrolase domain containing 14A) gene, as represented in GeneID:100526760. A related pseudogene has been identified on chromosome 18. [provided by RefSeq]
Specificity:
aminoacylase 1
Alternative names:
ACY-1; ACY1D; HEL-S-5
Species reactivity:
Human, Mouse, Rat, Dog
Host:
Mouse
Ig type:
PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Immunogen:
Full length human recombinant protein of human ACY1(NP_000657) produced in HEK293 cell.
Purification & Purity:
Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Molecular weight:
45.7 kDa(Predicted)
Applications:
FC, IHC, WB
Usage:
WB 1:200~500, IHC 1:150, FLOW 1:100
Storage:
PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Precautions:
For research use only, not for use in diagnostic procedure.
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
